CONFIDENTIAL TREATMENT REQUESTEDContribution Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
CONFIDENTIAL TREATMENT REQUESTEDSale and Purchase Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
The principles of interpretation set out in Clause 1 of the Original Agreement shall have effect as if set out in this Deed, save that references to “this Agreement” shall be construed as references to “this Deed”.
CONFIDENTIAL TREATMENT REQUESTEDShare and Business Sale Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
The principles of interpretation set out in Clause 1 of the Original Agreement shall have effect as if set out in this Deed, save that references to “this Agreement” shall be construed as references to “this Deed”.
CONFIDENTIAL TREATMENT REQUESTEDShareholders’ Agreement • March 18th, 2016 • Glaxosmithkline PLC • Pharmaceutical preparations
*** Note: Confidential treatment has been requested with respect to the information contained within the [***] marking. Such portions have been omitted from this filing and have been filed separately with the Securities and Exchange Commission.
